Sökning: "allogeneic stem cell transplantation"

Visar resultat 1 - 5 av 88 avhandlingar innehållade orden allogeneic stem cell transplantation.

  1. 1. Allogeneic stem cell transplantation : patients’ and sibling donors’ perspectives

    Författare :Annika M Kisch; Malmö högskola; []
    Nyckelord :Allogeneic haematopoietic stem cell transplantation; Confidentiality; Information and care model; Quality of life; Perspectives; Sibling donor; Stem cell donation;

    Sammanfattning : Allogeneic haematopoietic stem cell transplantation (hereafter HSCT) is an established treatment which offers a potential cure for a variety of diseases, mainly haematological malignancies. However, the treatment is also associated with significant risks of acute complications and late side effects, including mortality. LÄS MER

  2. 2. Life situation in patients and their family members after allogeneic hematopoietic stem cell transplantation : aspects of health and support in different care settings

    Författare :Karin Bergkvist; Joacim Larsen; Jonas Mattsson; Unn-Britt Johansson; Karin Ahlberg; Sophiahemmet Högskola; Karolinska Institutet; Karolinska Institutet; []
    Nyckelord :MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; MEDICIN OCH HÄLSOVETENSKAP; MEDICAL AND HEALTH SCIENCES; Allogeneic hematopoietic stem cell transplantation; Family member; Home care; Hospital care; Patient reported experiences; Patient reported outcomes; MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; allogeneic hematopoietic stem cell transplantation;

    Sammanfattning : Allogeneic hematopoietic stem cell transplantation (HSCT) is mainly an intensive treatment option for hematology malignancies. During the past decades, improved care and treatment have been systematically developed. LÄS MER

  3. 3. Alloreactivity in stem cell transplantation

    Författare :Anna Nordlander; Karolinska Institutet; Karolinska Institutet; []
    Nyckelord :MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP;

    Sammanfattning : Acute graft-versus-host disease (GVHD), relapse and graft rejection are the main complications after allogeneic hematopoietic stem cell transplantation (HSCT). The aim of this thesis was to achieve a better understanding of the alloreactivity seen after HSCT, focusing on graft rejection, but also including the graft-versus-leukemia (GVL) effect and GVHD. LÄS MER

  4. 4. Immune reconstitution after allogeneic hematopoietic stem cell transplantation

    Författare :Brigitta Omazic; Karolinska Institutet; Karolinska Institutet; []
    Nyckelord :MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP; Immune reconstitution; allogeneic haematopoietic stem cell transplantation; IgH gene expression; TcRVbeta gene expression; B lymphocytes; T lymphocytes; IGF-1 receptor; thyroid hormone receptor.;

    Sammanfattning : After treatment with allogeneic hernatopoietic stem cell transplantation (HSCT) the patient suffers from a deficient immune system for at least 12 months or longer. During this period, the patient is susceptible to infections and if the state of immune deficiency is prolonged there is an increased risk of relapse of the underlying malignancy as well as development of secondary malignancies. LÄS MER

  5. 5. Pulmonary complications after allogeneic hematopoietic stem cell transplantation

    Författare :Ulrica Forslöw; Karolinska Institutet; Karolinska Institutet; []
    Nyckelord :MEDICAL AND HEALTH SCIENCES; MEDICIN OCH HÄLSOVETENSKAP;

    Sammanfattning : The respiratory tract is one of the most common and serious sites for complications in HSCT patients. In this project the incidence, outcome, and risk factors for patients with infectious or non-infectious pulmonary complications were studied. Bronchoscopy and pulmonary function tests (PFTs) were evaluated as diagnostic tools. LÄS MER